Skip to main content

Imaging of Myocardial Amyloid Involvement with 99m — Tc Aprotinin

  • Chapter
Radioactive Isotopes in Clinical Medicine and Research

Part of the book series: Advances in Pharmacological Sciences ((APS))

  • 126 Accesses

Summary

We report on the use of 99m Tc-Aprotinin in the detection of myocardial amyloid involvement in a population of 45 pts with amyloidosis and 22 control subjects with renal and cardiac disease. Positive scans were obtained in 19 pts, no cardiac uptake was observed in the remaining 25 and in the controls. These results,confirmed by histology in 4 pts and by clinical-instrumental follow-up in 38, indicate TcA as a low-cost readily available tracer for cardiac amyloidosis detection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kyle RA,Gertz MA. Cardiac amyloidosis. Int J Cardiol 1990; 28: 139–141.

    Article  PubMed  CAS  Google Scholar 

  2. Merlini G, Marinone MG,Anesi EF,Ascari E. Report of an italian study protocol of AL amyloidosis. Blood 1994; 84 (suppl): 179a.

    Google Scholar 

  3. Aprile C, Marinone MG, Saponaro R,Bonino C,Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99 labelled Aprotinin. Eur J Nucl Med 1995; 22: 139–1401

    Article  Google Scholar 

  4. Merlini G. Treatment of primary amyloidosis. Semin Haematol 1995; 32: 60–79.

    CAS  Google Scholar 

  5. Gianni L,Bellotti V,Gianni AM,Merlini G. New drug therapy of amyloidoses: Resorption of AL-type deposits with 4’-iodo-4’deoxydoxorubicin. Blood 1995; 86: 855–861

    PubMed  CAS  Google Scholar 

  6. Carrol JD,Gaasch WH,Mc Adam KPWJ. Amyloid cardiomyopathy: carachterization by distinct voltage/mass relation. Am J Cardiol 1983; 52: 137–146.

    Article  Google Scholar 

  7. Hawkins PN,Lavender JP,Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123-I-labeled serum amyloid P component. N Engl J Med 1990; 325: 508–513.

    Article  Google Scholar 

  8. Aprile C,Saponaro R,Villa G, Lunghi F. 99mTc-Aprotinin: comparison with 99mTc-DMSA in normal and diseased kidneys. Nucl Med 1984; 23: 22–26.

    CAS  Google Scholar 

  9. Simons M, Isner JM. Assesment of relative sensitivities of non invasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 1992; 69: 425–427.

    Article  PubMed  CAS  Google Scholar 

  10. Falk RH, Plehn JF,Deering T et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987; 59: 418–422.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Basel AG

About this chapter

Cite this chapter

Aprile, C. et al. (1997). Imaging of Myocardial Amyloid Involvement with 99m — Tc Aprotinin. In: Bergmann, H., Kroiss, A., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7772-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7772-5_28

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-7774-9

  • Online ISBN: 978-3-0348-7772-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics